Heron Therapeutics (HRTX) P/E US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| P/E | ? | -4.07 | 0.00 | 0.00 | -17.2 | -10.7 | -2.56 | ||
| Changes by years, y/y, % | -52% | -100% | -38% | +4.9% | |||||
Heron Therapeutics. P/E
Heron Therapeutics. P/E, changes, %
Heron Therapeutics (HRTX) P/E US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| P/E | ? | -43.4 | -342.5 | -15.8 | -10.7 | -4.90 | -2.56 | |
| Changes by years, y/y, % | +45% | -38% | -89% | |||||
| Changes by quarters, q/q, % | +151% | +690% | -95% | -32% | -54% | |||